Activities per year
- 250 - 300 out of 2,300 results
Search results
-
Cytotoxic tetramic acid derivatives produced by a plant type-III polyketide synthase
Morita, H. (Speaker)
2012/05/28 → 2012/05/31Activity: Talk or presentation › Oral presentation
-
C-ヌクレオシドを天然 DNA 鎖末端に導入したキメラ DNA の酵素的ライゲーション
Chiba, J. (Speaker)
2015/06/10 → 2015/06/12Activity: Talk or presentation › Oral presentation
-
Factors related to subjective well-being and responsible molecules interacting the brain and the locomotor system.
Inada, Y. (Speaker)
2022Activity: Talk or presentation › Oral presentation
-
Deficiency of hypothalamic orexin causes insulin resistance via enhancement of ER stress in the liver of mice
Sasaoka, T. (Speaker)
2012/01/29 → 2012/02/03Activity: Talk or presentation › Oral presentation
-
Deficiency of hypothalamic orexin causes insulin resistance via enhancement of ER stress in the liver of mice
Wada, T. (Speaker)
2012/01/29 → 2012/02/03Activity: Talk or presentation › Oral presentation
-
Deficiency of hypothalamic orexin causes insulin resistance via enhancement of ER stress in the liver of mice
Tsuneki, H. (Speaker)
2012/01/29 → 2012/02/03Activity: Talk or presentation › Oral presentation
-
Deltamethrin, a type II pyrethroid insecticide, induces neurotrophic effects on neurons with a continuous activation of #IBdnf#IR promoter IV.
Ihara, D. (Speaker)
2011/08Activity: Talk or presentation › Oral presentation
-
Denervation of dopaminergic neuron with 6-hydroxydopamine increases nerve growth factor contents in rat brain.
Nitta, A. (Speaker)
1992/10/25 → 1992/10/30Activity: Talk or presentation › Oral presentation
-
De novo characterization of a #IPolygala tenuifolia#IR transcriptome and gene related onjisaponin biosynthesis.
Yamamura, Y. (Speaker)
2016/09/12 → 2016/09/13Activity: Talk or presentation › Oral presentation
-
De novo characterization of a Polygala tenuifolia transcriptome and gene related onjisaponin biosynthesis.
Lee, J. (Speaker)
2016/09/12 → 2016/09/13Activity: Talk or presentation › Oral presentation
-
Depletion of platelet-derived growth factor receptor β prevented adipose tissue expansion and insulin resistance in diet-induced obesity.
Tsuneki, H. (Speaker)
2015/10/25 → 2015/10/29Activity: Talk or presentation › Oral presentation
-
Depletion of platelet-derived growth factor receptor β prevented adipose tissue expansion and insulin resistance in diet-induced obesity.
Sasaoka, T. (Speaker)
2015/10/25 → 2015/10/29Activity: Talk or presentation › Oral presentation
-
Depletion of platelet-derived growth factor receptor β prevented adipose tissue expansion and insulin resistance in diet-induced obesity.
Wada, T. (Speaker)
2015/10/25 → 2015/10/29Activity: Talk or presentation › Oral presentation
-
Depletion of platelet-derived growth factor receptor β prevented adipose tissue expansion and insulin resistance in mice fed high-fat diet.
Sasaoka, T. (Speaker)
2015/10/30 → 2015/11/01Activity: Talk or presentation › Oral presentation
-
Depression, Anxiety Shati KOマウスは不安作用が減少し、学習能力には雌雄差がある Deletion of Shati/Nat8l in mice show antianxiety, and sexual differences of learning ability
Nitta, A. (Speaker)
2017/03/15 → 2017/03/17Activity: Talk or presentation › Oral presentation
-
Depression-like behaviors were induced by overexpression of Shati/Nat8l, an N-acetyltransferase, in the striatum of mice.
Nitta, A. (Speaker)
2014/06/22 → 2014/06/26Activity: Talk or presentation › Oral presentation
-
Design, Synthesis, and Biological Evaluation of Promising Anti-Alzheimer’s Compounds Having Dihydropyrone Unit as a Key Component.
Matsuya, Y. (Speaker)
2015/06/08 → 2015/06/11Activity: Talk or presentation › Oral presentation
-
Design and Screening of Novel Antimycin A3 Analogues as Anti-Breast Cancer Agents by Docking Approach
Tanimoto, H. (Speaker)
2013/06/18Activity: Talk or presentation › Oral presentation
-
Design and Syntheses of Denosomin-Vitamin D3 Hybrid Having Novel Anti-Alzheimer's Disease Effect.
Matsuya, Y. (Speaker)
2017/09/25 → 2017/09/26Activity: Talk or presentation › Oral presentation
-
Design and Synthesis of Furan-fused Perhydrophenanthrene Derivatives as a Novel Anti-Alzheimer’s Disease Agent.
Matsuya, Y. (Speaker)
2016/09/12 → 2016/09/13Activity: Talk or presentation › Oral presentation
-
Developmental expression of the SRF coactivator MAL and its role for dendritic morphology of cortical neurons.
Tabuchi, A. (Speaker)
2006/06Activity: Talk or presentation › Oral presentation
-
Development of a One-Pot 1,4-Dihydropyridine Synthesis by Auto-Tandem Catalysis of Cationic Gold Complex.
Matsuya, Y. (Speaker)
2017/07/24 → 2017/07/26Activity: Talk or presentation › Oral presentation
-
Development of Au-catalyzed Domino Reaction toward Biologically Important Alkaloids.
Matsuya, Y. (Speaker)
2013/08/11 → 2013/08/16Activity: Talk or presentation › Oral presentation
-
Development of behavioral and neurochemical abnormalities and the changes in the expression level of schizophrenia-related genes in a perinatal viral infection model.
Nitta, A. (Speaker)
2009/01/23Activity: Talk or presentation › Oral presentation
-
Development of Boronic Acid-catalyzed Nazarov Cyclization.
Matsuya, Y. (Speaker)
2018/09/16 → 2018/09/21Activity: Talk or presentation › Oral presentation
-
Development of Carbocation Mediated Azide-Alkyne Cyclization Reactions
Tanimoto, H. (Speaker)
2013/12/03Activity: Talk or presentation › Oral presentation
-
Development of crosslinked helical peptides that binds to a Vif-containing E3-ligase complex with remarkable affinity
Chiba, J. (Speaker)
2018/09/10 → 2018/09/12Activity: Talk or presentation › Oral presentation
-
Development of Electrophilic Amination with α-Oxime-esters
Tanimoto, H. (Speaker)
2012/11/20Activity: Talk or presentation › Oral presentation
-
Development of endoplasmic reticulum stress and insulin resistance in the liver of orexin knockout mice.
Tsuneki, H. (Speaker)
2012/03/18Activity: Talk or presentation › Oral presentation
-
Development of multi-functional photoactivatable crosslinkers for target protein analysis of bioactive small molecules
Tomohiro, T. (Speaker)
2019/01/16 → 2019/11/17Activity: Talk or presentation › Oral presentation
-
Development of Novel Synthetic Method for Substituted Quinolizidines from Alkynylamides Bearing an Allylic Silyl Group.
Matsuya, Y. (Speaker)
2017/09/25 → 2017/09/26Activity: Talk or presentation › Oral presentation
-
Development of schizophrenia-like behaviors and susceptibility gene expression in a viral infection model during perinatal stage.
Nitta, A. (Speaker)
2008/09/24Activity: Talk or presentation › Oral presentation
-
Development of S-Glucose Conjugated Porphyrins for PDT Drug Photosensitizer
Tanimoto, H. (Speaker)
2017/04/15Activity: Talk or presentation › Oral presentation
-
Development of Umpolung Functionalizations Using Nitrogen Functional Groups
Tanimoto, H. (Speaker)
2015/12/16Activity: Talk or presentation › Oral presentation
-
Diabetic neuropathies in brain are induced by deficiency of BDNF in rat brain.
Nitta, A. (Speaker)
2000/11/04 → 2000/11/09Activity: Talk or presentation › Oral presentation
-
Different effects of shati/nat8l-overexpression on the responses to methamphetamine between in of the nuclus accumbens and dorsal striatum in mice.
Nitta, A. (Speaker)
2013/11/09 → 2013/11/13Activity: Talk or presentation › Oral presentation
-
Different effects of shati/nat8l- overexpression on the responses to methamphetamine between in the nucleus accumbens and dorsal striatum in mice.
Nitta, A. (Speaker)
2013/03/14Activity: Talk or presentation › Oral presentation
-
Differential activation of BDNF promoters by calcium signals evoked via L-type-voltage dependent and NMDA receptor calcium channels.
Tabuchi, A. (Speaker)
2000/11Activity: Talk or presentation › Oral presentation
-
Differential blockade of action potentials by local anesthetics in rat dorsal root ganglion neurons.
Uta, D. (Speaker)
2005/11/12 → 2005/11/16Activity: Talk or presentation › Oral presentation
-
Differential epigenetic regulation of BDNF and NT-3 genes in Neuro-2a cells.
Tabuchi, A. (Speaker)
2010/10Activity: Talk or presentation › Oral presentation
-
Differential expression of rat SRF coactivator MKL1 transcripts during brain development: the possible involvement in dendritic morphology.
Tabuchi, A. (Speaker)
2011/08Activity: Talk or presentation › Oral presentation
-
Diosgenin is a candidate drug for stimulating axonal regeneration in the brain and recovering memory deficits in Alzheimer’s disease.
Tohda, C. (Speaker)
2021/11/30 → 2021/12/01Activity: Talk or presentation › Oral presentation
-
Diosgenin-rich yam extract enhances cognitive function: a placebo-controlled, randomized, double-blind, crossover study of healthy adults.
Tohda, C. (Speaker)
2021/09/01Activity: Talk or presentation › Oral presentation
-
Diosgeninがアルツハイマー病モデルマウスの脳内において軸索を再伸長させる分子メカニズムの解明.
Tohda, C. (Speaker)
2020/09/01Activity: Talk or presentation › Oral presentation
-
Diosgeninによって軸索が再伸長し記憶が改善する分子メカニズムの解明.
Tohda, C. (Speaker)
2021/09/01Activity: Talk or presentation › Oral presentation
-
Diosgeninによるアルツハイマー病脳内での軸索修復作用と臨床研究への展開.
Tohda, C. (Speaker)
2021/11/01Activity: Talk or presentation › Oral presentation
-
Diosgeninはアルツハイマー病の脳内において軸索を正しく再伸長させる.
Tohda, C. (Speaker)
2020/08/01Activity: Talk or presentation › Oral presentation
-
Diosgeninはアルツハイマー病モデルマウスの脳内において軸索を再伸長させ記憶障害を改善する。
Tohda, C. (Speaker)
2021/03/01Activity: Talk or presentation › Oral presentation
-
Diosgenin含有山薬エキスによる認知機能向上作用:マウスおよび健常人での検討.
Tohda, C. (Speaker)
2021/09/01Activity: Talk or presentation › Oral presentation
-
Dipeptide Leu-Ile has an anti-depressant like effect in a chronic forced swim test.
Nitta, A. (Speaker)
2008/09/24Activity: Talk or presentation › Oral presentation